Federated Hermes Global Equity Fund OCSE:NOVO B Holdings History
Federated Hermes Global Equity Fund's Novo Nordisk AS Holding Summary
As of 2024-08-31, Federated Hermes Adviser Series held 2,825.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr393,350.00. This investment constitutes 1.86% of their stock portfolio, and Federated Hermes Adviser Series now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then Federated Hermes Global Equity Fund has made 8 purchases of OCSE:NOVO B, at an average price of kr467.90, for a total of 13,596.00 shares. In addition, there have been 6 sales at an average price of kr635.30 for 10,771.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr438.95, Federated Hermes Global Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr1.72 Mil, reflecting a 27.06% gain to date.
Federated Hermes Global Equity Fund OCSE:NOVO B (kr438.95) Holding Chart
Federated Hermes Global Equity Fund OCSE:NOVO B (kr438.95) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price kr-/Share | ||
Shares Sold | 0 | Average Price kr-/Share | ||
Current Price kr0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1